EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS093-23518 
Organism
Homo sapiens 
Tissue/cell
HL-60 
Coordinate
chr4:40329030-40329870 
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Spz1MA0111.1chr4:40329363-40329374AGGGTATCAGC+6.32
ZEB1MA0103.3chr4:40329127-40329138GGGCAGGTGGG-6.14
ZEB1MA0103.3chr4:40329135-40329146GGGCAGGTGGG-6.14
ZNF263MA0528.1chr4:40329246-40329267AGAGGATGGGGGAGCGGGAGA+6.18
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_34942chr4:40329425-40331283HeLa
SE_39398chr4:40329003-40330433Jurkat
SE_49838chr4:40328601-40331262RPMI-8402
SE_59890chr4:40298969-40330699Ly4
SE_66318chr4:40329003-40330433Jurkat
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr44032953440329600
Number: 1             
IDChromosomeStartEnd
GH04I040327chr44032944140329590
Enhancer Sequence
TGCTTCCTTC CAAACATGCT TCCAGAAGCA GGCACCTAGG CCATTCATAC CCACGGGGCT 60
GCTCTCGGCT AAGTAGGCCT AGCCGAAGAG ACACTGAGGG CAGGTGGGCA GGTGGGGTGG 120
GAGATGGAGC AGCGCGTTGC TGACTGGGAG AAAGCACCTC CTTGCCTCTT TTCAGTTTTA 180
ACATGTCCCT TTAGTGCCCA CTTTCCAGAA CAGGGCAGAG GATGGGGGAG CGGGAGATGA 240
GTGAGGTCTT GGGGCCATGG GGCCATGCTG CTTCTAAGGG GGCAGAAGCT GTGGGAGAGG 300
TTGGGGGCTG GTAGCTCTCA GAATAGCCTG GGAAGGGTAT CAGCTGGGTT TGCACAGTGT 360
TGTCTCCGAA TCTCCCAGCT CCCCTTCTCT ATGATTAGCA TCCTTGAAGT AGCGTGCTAC 420
TGTTAACAGA AGAGCAGAGT GTGCCCCTTC TGCTTTTTCC CATGCTTGTC ATTTGCCTAA 480
CTCTTACAAT GTTAGCAGAG AGACAGTGTT TGCAACGAGC AGGGAAATAT TGCACAATTG 540
TGACTGCAGG GTCTGCTATG AGAAGAGGAA GCAGAGCCAG TGGGGTGAGA ACCTCCTGGG 600
ATGAGAAGGG GTCGGAAACT CAAGAACAAA GGAAAATGTC TGAGAAGTCC CAAGGAGCAA 660
GTGGGCTACC ATTGAGGACA GAAATCTCCC ATGGATGAGG TCTCCTCTGT GCAGCAAAGA 720
AAGACCCCAG AAACAGGAGG AAGCCAGGAG ATACTCACCC TATACCACAC TGTACAGTTT 780
TATAGCTTTC AAATATATTC CCTCAGGGGA TTTCAGGGAA AATAGTATGC ACCCTCTGAC 840